A multi-omics machine learning classifier for outgrowth of cow's milk allergy in children.

Journal: Molecular omics
Published Date:

Abstract

Cow's milk protein allergy (CMA) is one of the most common food allergies in children worldwide. However, it is still not well understood why certain children outgrow their CMA and others do not. While there is increasing evidence for a link of CMA with the gut microbiome, it is still unclear how the gut microbiome and metabolome interact with the immune system. Integrating data from different omics platforms and clinical data can help to unravel these interactions. In this study, we integrate clinical, microbial, (meta)proteomics, immune and metabolomics data into machine learning (ML) classification, using multi-view learning by late integration. The aim is to group infants into those that outgrew their CMA and those that did not. The results show that integration of microbiome data with clinical, immune, (meta)proteomics and metabolomics data could considerably improve classification of infants on outgrowth of CMA, compared to only considering one type of data. Moreover, pathways previously linked to development of CMA could also be related to outgrowth of this allergy.

Authors

  • Diana M Hendrickx
    Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands. clara.belzer@wur.nl.
  • Mariyana V Savova
    Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
  • Pingping Zhu
    Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
  • Ran An
    Department of Anesthesiology, Chongqing University Cancer Hospital, Chongqing, China.
  • Sjef Boeren
    Laboratory of Biochemistry, Wageningen University, Wageningen, The Netherlands.
  • Kelly Klomp
    Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands. clara.belzer@wur.nl.
  • Sumanth K Mutte
    Laboratory of Biochemistry, Wageningen University, Wageningen, The Netherlands.
  • Presto Study Team
  • Harm Wopereis
    Danone Nutricia Research, Utrecht, The Netherlands.
  • Renate G van der Molen
    Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboudumc, Nijmegen, The Netherlands.
  • Amy C Harms
    Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
  • Clara Belzer
    Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands. clara.belzer@wur.nl.